Douglas Labs Stress-B-Plus Dietary Supplement, Tablets, 90 tablets per bottle.
Recalling firm: Nestle Product Technology Center - Nestle Health Science
Nestle Health Science (NHS U.S., LLC) is initiating a recall of Douglas Labs Stress-B-Plus Dietary Supplement Tablets, 90 tablets per bottle. The bottle is white and made of…
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Jun 24, 2026.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Lot Codes: 50335944, 50344396
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Douglas Labs Stress-B-Plus Dietary Supplement, Tablets, 90 tablets per bottle. UPC # 10539 97452, Lot Numbers ,50335944 and 50344396. Expiration Date 04/11/2026
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| expiration | 04/11/2026 | bottle. UPC # 10539 97452, Lot Numbers ,50335944 and 50344396. Expiration Date 04/11/2026 |
| lot | 50335944 | Lot Codes: 50335944, 50344396 |
| lot | 50344396 | Lot Codes: 50335944, 50344396 |
Original FDA recall reason
Nestle Health Science (NHS U.S., LLC) is initiating a recall of Douglas Labs Stress-B-Plus Dietary Supplement Tablets, 90 tablets per bottle. The bottle is white and made of plastic. Lot Numbers 50335944,50344396, expiration date 04/11/2026. The product is being recalled because of Incorrect formulation manufactured vs label claims. Product was manufactured with Niacin (as Nicotinic acid) and supplement facts panel states contains Niacin (as Niacinamide).
Recall details
- Recall number
- F-0139-2025
- Event ID
- 95519
- FDA status
- Terminated
- Initiated
- Oct 7, 2024
- Reported
- Nov 27, 2024
- Classified
- Nov 17, 2024
- Terminated
- Jun 24, 2026
- Quantity
- 3,269 bottles in market
- Location
- Bridgewater, NJ, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
AK,AZ,CA,CO,DE,FL,GA,IA,ID,IL,IN,KS,KY,LA,MA,MD,MI,MN,MO,NC,NH,NJ,NM,NY,OH,OK,OR,PA,SD,TN,TX,VA,WA,WI,WV
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.